CVS Health Corporation $CVS Stock Position Decreased by New York State Teachers Retirement System

New York State Teachers Retirement System decreased its position in CVS Health Corporation (NYSE:CVS) by 1.7% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,054,673 shares of the pharmacy operator’s stock after selling 18,315 shares during the quarter. New York State Teachers Retirement System’s holdings in CVS Health were worth $79,512,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Avion Wealth increased its stake in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the last quarter. Harbor Asset Planning Inc. bought a new position in CVS Health during the second quarter valued at about $30,000. Front Row Advisors LLC lifted its position in shares of CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC increased its holdings in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.4%

Shares of CVS opened at $80.29 on Friday. The stock’s 50-day moving average price is $78.70 and its 200 day moving average price is $73.88. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $101.92 billion, a price-to-earnings ratio of 211.29, a P/E/G ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a 12-month low of $46.34 and a 12-month high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is currently 700.00%.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of recent analyst reports. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Wells Fargo & Company decreased their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Mizuho raised their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. UBS Group restated an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. Finally, Raymond James Financial upped their price target on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.